SCHEMBL7773116

SCHEMBL7773116

CCCCOc1ccc(-c2c[nH]nc2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 13/20 0.63
CA9 Q16790 13/20 0.63
CA1 P00915 12/20 0.63
CA12 O43570 10/20 0.63
CA7 P43166 7/20 0.63
TSHR P16473 1/20 0.63
CA14 Q9ULX7 1/20 0.46
ENPP3 O14638 1/20 0.44
MAPT P10636 1/20 0.44
CA4 P22748 5/20 0.44
HRH3 Q9Y5N1 3/20 0.42
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
KCNH2 Q12809 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780635 0.90 CA2 (0.61) CA2CA9CA1CA12CA7
SCHEMBL7779277 0.89 PTGS2 (0.49) CA2CA9CA1CA12CA7
SCHEMBL7773144 0.83 PTGS2 (0.55) CA2CA9CA1CA12CA7
SCHEMBL7779925 0.80 PTGS2 (0.54) CA2CA9CA1CA12CA7
SCHEMBL615392 0.80 CA2 (1.00) CA2CA9CA1CA12CA7
SCHEMBL7780061 0.79 CA12 (0.56) CA2CA9CA1CA12CA7
SCHEMBL7777657 0.79 PTGS2 (0.50) CA2CA9CA1CA12CA7
SCHEMBL7780009 0.78 CA2 (0.44) CA2CA9CA1CA12CA7
SCHEMBL7780654 0.78 PTGS2 (0.62) PTGS2PTGS1
SCHEMBL7779645 0.78 LRRK2 (0.50) CA2CA9CA1CA12PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed